Original Research
Published on 17 Sep 2025
Influence of divalent metal ions on gelation of a short heterochiral peptide
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1673051
- 460 views
143 Publications
Volume 5 - 2025
Original Research
Published on 10 Sep 2025
Bioinformatics-driven identification and prioritization of PTSD targets based on published multi-omic data
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1613261
- 976 views
Perspective
Published on 03 Sep 2025
Advancing histone deacetylase 6 (HDAC6) as a promising therapeutic target for Alzheimer’s disease: from molecular insights to clinical prospects
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1662691
- 839 views
Opinion
Published on 25 Aug 2025
On the biologically relevant chemical space: BioReCS
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1674289
- 1,775 views
Mini Review
Published on 26 Jun 2025
AI-driven innovation in antibody-drug conjugate design
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1628789
- 4,996 views
- 2 citations
Editorial
Published on 10 Jun 2025
Editorial: Pharmacokinetics modeling in the Artificial Intelligence Era
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1636070
- 1,432 views
Original Research
Published on 06 Jun 2025
Dual upregulation of miRNA-143 and miRNA-506 in non-small cell lung cancer inhibits proliferation, motility, migration, and tumor growth
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1584801
- 1,672 views
Editorial
Published on 04 Jun 2025
Editorial: Enhancing drug discovery through structure-based design and computational techniques
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1632015
- 1,422 views
Original Research
Published on 30 May 2025
Safety and tolerability of a bevacizumab biosimilar (Effivia®) in adult Mexican patients with cancer: a multicenter, observational, prospective clinical study
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1591991
- 1,200 views
Original Research
Published on 15 Apr 2025
Identification of natural compounds as potential inhibitors of Interleukin-23: virtual screening, ADMET, drug-likeness, and dynamic simulation
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1525533
- 2,031 views
- 4 citations
Original Research
Published on 21 Feb 2025
Transduction of hematopoietic stem and progenitor cells by an MECP2 lentiviral vector improves Rett syndrome phenotypes
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1545391
- 1,677 views
Editorial
Published on 20 Feb 2025
Editorial: Exploring drug development with single cell omics analytics and stem cell-based disease models
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1561985
- 1,132 views
Perspective
Published on 19 Feb 2025
Perspective: How complex in vitro models are addressing the challenges of predicting drug-induced liver injury
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1536756
- 4,296 views
- 1 citation
Review
Published on 29 Jan 2025
Non-enzymatic protein targeting agents as a promising strategy for cancer treatment
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1520734
- 4,558 views
Volume 4 - 2024
Original Research
Published on 03 Jan 2025
Validation of an MPS-based intestinal cell culture model for the evaluation of drug-induced toxicity
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1459424
- 3,217 views
- 3 citations
Review
Published on 19 Dec 2024
Targeting steroid receptor coactivators in cancer via small molecule agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1514412
- 1,473 views
- 1 citation